Delivery Order SPE2DB22D1017-SPE2DB25FYPCU
- Not listed
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $5,360.72 for Zepbound 7.5 mg/0.5 mL pens on August 1, 2025, with an ultimate completion date of August 4, 2025. This competitive, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a...
- The Defense Logistics Agency awarded a delivery order valued at $4,956.77 to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Zepbound 10 mg/0.5 ml pens with an ultimate completion date of August 29, 2025. The contract utilizes firm fixed price pricing with no set-aside designation and represents a competitively awarded delivery order. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $11,312.79 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens. The contract, with an ultimate completion date of August 27, 2025, represents a non-set-aside competitive procurement executed through the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on October 17, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens with a ceiling value of approximately $14.8K. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 20, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $65,338 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Zepbound 15 mg/0.5 mL pens. This competitively awarded contract, which carries a completion date of September 24, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order under a larger contract vehicle, this award leverages AmerisourceBergen's established relationship with...
- The Defense Logistics Agency awarded a delivery order valued at $7,242.81 to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 ml pens on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the company's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 30, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pens at a ceiling value of $1,525.20. This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order with performance to be completed by July 1, 2025, with fulfillment occurring at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order falls under the company's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $1,306.78 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Zepbound 5 mg/0.5 mL pens. This competitive award, with a completion date of July 30, 2025, represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply arrangements with the federal government. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania location, where the company operates as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 mL pens on August 15, 2025, with a ceiling value of $8,246.40 and an ultimate completion date of August 18, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $15,251.60 on August 15, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections. The contract, designated as a firm fixed price delivery order with an ultimate completion date of August 18, 2025, represents a non-competitive set-aside award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYPCUDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,557.45 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on August 26, 2025, with completion scheduled for August 27, 2025. This is a firm fixed price contract with no set-aside designation, awarded through open competition. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary distribution operations. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems globally. The current delivery order for Zepbound, a diabetes and weight management medication, reflects the company's role as a critical vendor in the federal medical supply chain serving the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.6k | 8/26/25 |